Diplomat Pharmacy (DPLO) Tops Q2 EPS by 4c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Diplomat Announces 2nd Quarter 2015 Financial Results
August 3, 2015 4:05 PM EDTFLINT, Mich., Aug. 3, 2015 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced financial results for the quarter ended June 30, 2015. All comparisons, unless otherwise noted, are to the quarter ended June 30, 2014.
Second Quarter 2015 Highlights include:
Revenue of $808 million, an increase of 49% or $266 million Total prescriptions dispensed of 234,000, an increase of 19% Gross margin of 8.6% versus 5.5% Adjusted EBITDA of $22.7 million, an increase of 287% or $16.8 million Adjusted EPS of... More